PF-05085727

PF-05085727

Biochem/physiol Actions

PF-05085727 is a potent inhibitor against cGMP-dependent phosphodiesterase PDE2 (PDE2A; IC50 = 2.3 nM) with >500-fold selectivity over other PDEs. Its 3-[(18)F]fluoroazetidinyl derivative ([(18)F]PF-05270430) has been successfully applied via i.v. injection as a brain-permeant probe for imaging brain PDE2 in live cynomolgus monkeys by positron emission tomography (PET).

Legal Information

Pfizer is a registered trademark of Pfizer, Inc.

Sold for research purposes under agreement from Pfizer Inc.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Solubility Form Assay Price Quantity
3573808 PF-05085727 white to beige 100 SIGMA-ALDRICH DMSO: 2 mg/mL, clear
£435.96 (exc VAT) per 25MG
-
+
3573809 PF-05085727 white to beige 100 SIGMA-ALDRICH DMSO: 2 mg/mL, clear
£119.37 (exc VAT) per 5MG
-
+